Robin Pieter Frank Dullaart - Publications

Affiliations: 
1990 Utrecht University, Utrecht, Netherlands 

72/187 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Sato M, Neufeld EB, Playford MP, Lei Y, Sorokin AV, Aponte AM, Freeman LA, Gordon SM, Dey AK, Jeiran K, Hamasaki M, Sampson ML, Shamburek RD, Tang J, Chen MY, ... ... Dullaart RP, et al. Cell-free high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular disease. The Journal of Clinical Investigation. PMID 37471145 DOI: 10.1172/JCI165370  0.401
2016 Annema W, Willemsen HM, de Boer JF, Dikkers A, van der Giet M, Nieuwland W, Muller Kobold AC, van Pelt LJ, Slart RH, van der Horst IC, Dullaart RP, Tio RA, Tietge UJ. HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels. Journal of Clinical Lipidology. 10: 1318-1328. PMID 27919348 DOI: 10.1016/j.jacl.2016.08.003  0.41
2016 Annema W, Dikkers A, de Boer JF, van Greevenbroek MM, van der Kallen CJ, Schalkwijk CG, Stehouwer CD, Dullaart RP, Tietge UJ. Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study. Scientific Reports. 6: 27367. PMID 27270665 DOI: 10.1038/srep27367  0.416
2015 van Tienhoven-Wind LJ, Perton FG, Dullaart RP. Pre-β-HDL formation relates to high-normal free thyroxine in type 2 diabetes mellitus. Clinical Biochemistry. 49: 41-6. PMID 26320015 DOI: 10.1016/j.clinbiochem.2015.08.024  0.412
2015 Gruppen EG, Connelly MA, Otvos JD, Bakker SJ, Dullaart RP. A novel protein glycan biomarker and LCAT activity in metabolic syndrome. European Journal of Clinical Investigation. 45: 850-9. PMID 26081900 DOI: 10.1111/Eci.12481  0.341
2015 Koopal C, Retterstøl K, Sjouke B, Hovingh GK, Ros E, de Graaf J, Dullaart RP, Bertolini S, Visseren FL. Vascular risk factors, vascular disease, lipids and lipid targets in patients with familial dysbetalipoproteinemia: a European cross-sectional study. Atherosclerosis. 240: 90-7. PMID 25768710 DOI: 10.1016/j.atherosclerosis.2015.02.046  0.395
2015 van Tienhoven-Wind LJ, Dullaart RP. Low-normal thyroid function and novel cardiometabolic biomarkers. Nutrients. 7: 1352-77. PMID 25690422 DOI: 10.3390/nu7021352  0.353
2015 van Tienhoven-Wind L, Dullaart RP. Low normal thyroid function as a determinant of increased large very low density lipoprotein particles. Clinical Biochemistry. 48: 489-94. PMID 25666190 DOI: 10.1016/j.clinbiochem.2015.01.015  0.384
2015 Dullaart RP, de Vries R, Kwakernaak AJ, Perton F, Dallinga-Thie GM. Increased large VLDL particles confer elevated cholesteryl ester transfer in diabetes. European Journal of Clinical Investigation. 45: 36-44. PMID 25402623 DOI: 10.1111/eci.12377  0.531
2014 Abbasi A, Dallinga-Thie GM, Dullaart RP. Phospholipid transfer protein activity and incident type 2 diabetes mellitus. Clinica Chimica Acta; International Journal of Clinical Chemistry. 439: 38-41. PMID 25304745 DOI: 10.1016/j.cca.2014.09.035  0.348
2014 Dullaart RP, de Vries R, Lefrandt JD. Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus. Clinical Biochemistry. 47: 170-5. PMID 25149194 DOI: 10.1016/j.clinbiochem.2014.08.008  0.386
2014 Kwakernaak AJ, Lambert G, Dullaart RP. Plasma proprotein convertase subtilisin-kexin type 9 is predominantly related to intermediate density lipoproteins. Clinical Biochemistry. 47: 679-82. PMID 24680982 DOI: 10.1016/j.clinbiochem.2014.03.008  0.39
2014 Triolo M, Annema W, de Boer JF, Tietge UJ, Dullaart RP. Simvastatin and bezafibrate increase cholesterol efflux in men with type 2 diabetes. European Journal of Clinical Investigation. 44: 240-8. PMID 24325778 DOI: 10.1111/eci.12226  0.468
2013 Slagter SN, van Vliet-Ostaptchouk JV, Vonk JM, Boezen HM, Dullaart RP, Kobold AC, Feskens EJ, van Beek AP, van der Klauw MM, Wolffenbuttel BH. Associations between smoking, components of metabolic syndrome and lipoprotein particle size. Bmc Medicine. 11: 195. PMID 24228807 DOI: 10.1186/1741-7015-11-195  0.351
2013 Triolo M, Annema W, Dullaart RP, Tietge UJ. Assessing the functional properties of high-density lipoproteins: an emerging concept in cardiovascular research. Biomarkers in Medicine. 7: 457-72. PMID 23734809 DOI: 10.2217/bmm.13.35  0.407
2013 Abbasi A, Corpeleijn E, Gansevoort RT, Gans RO, Hillege HL, Stolk RP, Navis G, Bakker SJ, Dullaart RP. Role of HDL cholesterol and estimates of HDL particle composition in future development of type 2 diabetes in the general population: the PREVEND study. The Journal of Clinical Endocrinology and Metabolism. 98: E1352-9. PMID 23690306 DOI: 10.1210/jc.2013-1680  0.469
2013 Triolo M, Kwakernaak AJ, Perton FG, de Vries R, Dallinga-Thie GM, Dullaart RP. Low normal thyroid function enhances plasma cholesteryl ester transfer in Type 2 diabetes mellitus. Atherosclerosis. 228: 466-71. PMID 23591416 DOI: 10.1016/j.atherosclerosis.2013.03.009  0.409
2013 Dullaart RP, de Boer JF, Annema W, Tietge UJ. The inverse relation of HDL anti-oxidative functionality with serum amyloid a is lost in metabolic syndrome subjects. Obesity (Silver Spring, Md.). 21: 361-6. PMID 23404653 DOI: 10.1002/oby.20058  0.315
2013 de Vries R, Dikkeschei BD, Sluiter WJ, Dallinga-Thie GM, van Tol A, Dullaart RP. Statin and fibrate combination does not additionally lower plasma cholesteryl ester transfer in type 2 diabetes mellitus. Clinical Laboratory. 58: 1231-9. PMID 23289194  0.506
2013 Kwakernaak AJ, Lambert G, Muller Kobold AC, Dullaart RP. Adiposity blunts the positive relationship of thyrotropin with proprotein convertase subtilisin-kexin type 9 levels in euthyroid subjects. Thyroid : Official Journal of the American Thyroid Association. 23: 166-72. PMID 23106476 DOI: 10.1089/thy.2012.0434  0.383
2012 Kappelle PJ, Gansevoort RT, Hillege HJ, Wolffenbuttel BH, Dullaart RP. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio. Journal of Clinical Lipidology. 7: 56-64. PMID 23351584 DOI: 10.1016/j.jacl.2012.05.003  0.464
2012 Kwakernaak AJ, Lambert G, Slagman MC, Waanders F, Laverman GD, Petrides F, Dikkeschei BD, Navis G, Dullaart RP. Proprotein convertase subtilisin-kexin type 9 is elevated in proteinuric subjects: relationship with lipoprotein response to antiproteinuric treatment. Atherosclerosis. 226: 459-65. PMID 23261172 DOI: 10.1016/j.atherosclerosis.2012.11.009  0.366
2012 van Schouwenburg IM, Mahmoodi BK, Gansevoort RT, Muntinghe FL, Dullaart RP, Kluin-Nelemans HC, Veeger NJ, Meijer K. Lipid levels do not influence the risk of venous thromboembolism. Results of a population-based cohort study. Thrombosis and Haemostasis. 108: 923-9. PMID 22955992 DOI: 10.1160/TH12-06-0426  0.416
2012 Constantinides A, de Vries R, van Leeuwen JJ, Gautier T, van Pelt LJ, Tselepis AD, Lagrost L, Dullaart RP. Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity. European Journal of Internal Medicine. 23: 633-8. PMID 22902096 DOI: 10.1016/j.ejim.2012.05.008  0.38
2012 Kappelle PJ, Dullaart RP, van Beek AP, Hillege HL, Wolffenbuttel BH. The plasma leptin/adiponectin ratio predicts first cardiovascular event in men: a prospective nested case-control study. European Journal of Internal Medicine. 23: 755-9. PMID 22819464 DOI: 10.1016/j.ejim.2012.06.013  0.336
2012 Di Angelantonio E, Gao P, Pennells L, Kaptoge S, Caslake M, Thompson A, Butterworth AS, Sarwar N, Wormser D, Saleheen D, Ballantyne CM, Psaty BM, Sundström J, Ridker PM, ... ... Dullaart RP, et al. Lipid-related markers and cardiovascular disease prediction. Jama. 307: 2499-506. PMID 22797450 DOI: 10.1001/Jama.2012.6571  0.304
2012 Corsetti JP, Bakker SJ, Sparks CE, Dullaart RP. Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein. Plos One. 7: e39110. PMID 22723940 DOI: 10.1371/journal.pone.0039110  0.35
2012 Dullaart RP, Annema W, de Boer JF, Tietge UJ. Pancreatic β-cell function relates positively to HDL functionality in well-controlled type 2 diabetes mellitus. Atherosclerosis. 222: 567-73. PMID 22541874 DOI: 10.1016/j.atherosclerosis.2012.03.037  0.368
2012 Constantinides A, Kappelle PJ, Lambert G, Dullaart RP. Plasma lipoprotein-associated phospholipase A2 is inversely correlated with proprotein convertase subtilisin-kexin type 9. Archives of Medical Research. 43: 11-4. PMID 22300679 DOI: 10.1016/j.arcmed.2012.01.001  0.387
2012 Corsetti JP, Gansevoort RT, Bakker SJ, Navis G, Sparks CE, Dullaart RP. Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein. Metabolism: Clinical and Experimental. 61: 996-1002. PMID 22225956 DOI: 10.1016/j.metabol.2011.11.010  0.376
2012 Kappelle PJ, de Boer JF, Perton FG, Annema W, de Vries R, Dullaart RP, Tietge UJ. Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL. European Journal of Clinical Investigation. 42: 487-95. PMID 21955281 DOI: 10.1111/j.1365-2362.2011.02604.x  0.408
2011 de Vries R, Perton FG, van Tol A, Dullaart RP. Carotid intima media thickness is related positively to plasma pre ß-high density lipoproteins in non-diabetic subjects. Clinica Chimica Acta; International Journal of Clinical Chemistry. 413: 473-7. PMID 22100832 DOI: 10.1016/j.cca.2011.11.001  0.446
2011 Mulder DJ, de Boer JF, Graaff R, de Vries R, Annema W, Lefrandt JD, Smit AJ, Tietge UJ, Dullaart RP. Skin autofluorescence is inversely related to HDL anti-oxidative capacity in type 2 diabetes mellitus. Atherosclerosis. 218: 102-6. PMID 21665206 DOI: 10.1016/j.atherosclerosis.2011.05.011  0.304
2011 Kappelle PJ, Perton F, Hillege HL, Dallinga-Thie GM, Dullaart RP. High plasma cholesteryl ester transfer but not CETP mass predicts incident cardiovascular disease: a nested case-control study. Atherosclerosis. 217: 249-52. PMID 21524747 DOI: 10.1016/j.atherosclerosis.2011.03.020  0.317
2011 de Vries R, Groen AK, Dullaart RP. Cholesterol efflux capacity and atherosclerosis. The New England Journal of Medicine. 364: 1473-4; author reply. PMID 21488781 DOI: 10.1056/NEJMc1101853  0.41
2011 Dullaart RP, Constantinides A, Perton FG, van Leeuwen JJ, van Pelt JL, de Vries R, van Tol A. Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile. The Journal of Clinical Endocrinology and Metabolism. 96: 1077-84. PMID 21252249 DOI: 10.1210/jc.2010-2139  0.404
2010 Corsetti JP, Gansevoort RT, Navis G, Sparks CE, Dullaart RP. LPL polymorphism (D9N) predicts cardiovascular disease risk directly and through interaction with CETP polymorphism (TaqIB) in women with high HDL cholesterol and CRP. Atherosclerosis. 214: 373-6. PMID 21146168 DOI: 10.1016/j.atherosclerosis.2010.11.029  0.331
2010 Kappelle PJ, Lambert G, Dullaart RP. Plasma proprotein convertase subtilisin-kexin type 9 does not change during 24h insulin infusion in healthy subjects and type 2 diabetic patients. Atherosclerosis. 214: 432-5. PMID 21122860 DOI: 10.1016/j.atherosclerosis.2010.10.028  0.382
2010 Kappelle PJ, Ahnström J, Dikkeschei BD, de Vries R, Sluiter WJ, Wolffenbuttel BH, van Tol A, Nielsen LB, Dahlbäck B, Dullaart RP. Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus. Atherosclerosis. 213: 247-50. PMID 20828695 DOI: 10.1016/J.Atherosclerosis.2010.07.048  0.372
2010 Kappelle PJ, van Tol A, Wolffenbuttel BH, Dullaart RP. Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion. Cardiovascular Therapeutics. 29: e89-99. PMID 20645987 DOI: 10.1111/j.1755-5922.2010.00201.x  0.43
2010 Vergeer M, Boekholdt SM, Sandhu MS, Ricketts SL, Wareham NJ, Brown MJ, de Faire U, Leander K, Gigante B, Kavousi M, Hofman A, Uitterlinden AG, van Duijn CM, Witteman JC, Jukema JW, ... ... Dullaart RP, et al. Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility. Circulation. 122: 470-7. PMID 20644014 DOI: 10.1161/Circulationaha.109.912519  0.375
2010 Dullaart RP. Increased coronary heart disease risk determined by high high-density lipoprotein cholesterol and C-reactive protein: modulation by variation in the CETP gene. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 1502-3. PMID 20631348 DOI: 10.1161/ATVBAHA.110.209544  0.338
2010 Corsetti JP, Gansevoort RT, Sparks CE, Dullaart RP. Inflammation reduces HDL protection against primary cardiac risk. European Journal of Clinical Investigation. 40: 483-9. PMID 20412290 DOI: 10.1111/j.1365-2362.2010.02287.x  0.351
2010 Krikken JA, Gansevoort RT, Dullaart RP. Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease. Journal of Lipid Research. 51: 1982-90. PMID 20211930 DOI: 10.1194/jlr.M005348  0.301
2009 Dullaart RP, van den Berg G, van der Knaap AM, Dijck-Brouwer J, Dallinga-Thie GM, Zelissen PM, Sluiter WJ, van Beek AP. HDL cholesterol response to GH replacement is associated with common cholesteryl ester transfer protein gene variation (-629C>A) and modified by glucocorticoid treatment. European Journal of Endocrinology. 162: 227-34. PMID 19926784 DOI: 10.1530/EJE-09-0742  0.448
2009 Kappelle PJ, Dallinga-Thie GM, Dullaart RP. Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targets. Biochimica Et Biophysica Acta. 1801: 89-94. PMID 19800983 DOI: 10.1016/j.bbalip.2009.09.021  0.463
2009 Dullaart RP, Perton F, van der Klauw MM, Hillege HL, Sluiter WJ. High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: possible attenuation of cardioprotection associated with high HDL cholesterol. Atherosclerosis. 208: 537-42. PMID 19698944 DOI: 10.1016/j.atherosclerosis.2009.07.042  0.444
2009 Kappelle PJ, Zwang L, Huisman MV, Banga JD, Sluiter WJ, Dallinga-Thie GM, Dullaart RP. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein. Expert Opinion On Therapeutic Targets. 13: 743-51. PMID 19505224 DOI: 10.1517/14728220903023866  0.49
2009 Dullaart RP, de Vries R, Sluiter WJ, Voorbij HA. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus. Clinical Endocrinology. 70: 221-6. PMID 18505467 DOI: 10.1111/j.1365-2265.2008.03306.x  0.364
2008 Dullaart RP, Perton F, Sluiter WJ, de Vries R, van Tol A. Plasma lecithin: cholesterol acyltransferase activity is elevated in metabolic syndrome and is an independent marker of increased carotid artery intima media thickness. The Journal of Clinical Endocrinology and Metabolism. 93: 4860-6. PMID 18782872 DOI: 10.1210/jc.2008-1213  0.431
2008 Dullaart RP, Sluiter WJ. Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis. Pharmacogenomics. 9: 747-63. PMID 18518852 DOI: 10.2217/14622416.9.6.747  0.319
2008 Dallinga-Thie GM, Dullaart RP, van Tol A. Derangements of intravascular remodeling of lipoproteins in type 2 diabetes mellitus: consequences for atherosclerosis development. Current Diabetes Reports. 8: 65-70. PMID 18367001 DOI: 10.1007/s11892-008-0012-3  0.527
2008 Dullaart RP, Schols JL, van der Steege G, Zelissen PM, Sluiter WJ, van Beek AP. Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients. Clinical Endocrinology. 69: 359-66. PMID 18221399 DOI: 10.1111/j.1365-2265.2008.03196.x  0.422
2008 Dullaart RP, Groen AK, Dallinga-Thie GM, de Vries R, Sluiter WJ, van Tol A. Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol. European Journal of Endocrinology. 158: 53-60. PMID 18166817 DOI: 10.1530/EJE-07-0451  0.439
2007 Dullaart RP, Dallinga-Thie GM, van Tol A. Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo. Clinical Endocrinology. 67: 316-7; author reply . PMID 17524037 DOI: 10.1111/j.1365-2265.2007.02866.x  0.322
2007 Dallinga-Thie GM, Dullaart RP, van Tol A. Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins. Current Opinion in Lipidology. 18: 251-7. PMID 17495597 DOI: 10.1097/MOL.0b013e3280e12685  0.514
2007 Borggreve SE, Hillege HL, Dallinga-Thie GM, de Jong PE, Wolffenbuttel BH, Grobbee DE, van Tol A, Dullaart RP. High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides. European Heart Journal. 28: 1012-8. PMID 17409111 DOI: 10.1093/eurheartj/ehm062  0.33
2006 Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Zuurman MW, van der Steege G, van Tol A, Dullaart RP. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study. The Journal of Clinical Endocrinology and Metabolism. 91: 3382-8. PMID 16684835 DOI: 10.1210/jc.2005-2322  0.445
2006 de Vries R, Perton FG, Dallinga-Thie GM, van Roon AM, Wolffenbuttel BH, van Tol A, Dullaart RP. Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides. Diabetes. 54: 3554-9. PMID 16306375 DOI: 10.2337/diabetes.54.12.3554  0.376
2005 Vogt L, Laverman GD, van Tol A, Groen AK, Navis G, Dullaart RP. Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 21: 101-6. PMID 16141462 DOI: 10.1093/ndt/gfi068  0.448
2005 De Vries R, Wolffenbuttel BH, Sluiter WJ, van Tol A, Dullaart RP. Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects. Clinical Laboratory. 51: 403-9. PMID 16122151  0.347
2005 Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Bakker SJ, van der Steege G, van Tol A, Dullaart RP. The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides. The Journal of Clinical Endocrinology and Metabolism. 90: 4198-204. PMID 15840744 DOI: 10.1210/jc.2005-0182  0.398
2004 de Vries R, Borggreve SE, Dullaart RP. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus. Clinical Laboratory. 49: 601-13. PMID 14651331  0.527
2000 De Graaf JS, Dullaart RP, Kok T, Piers DA, Zwierstra RP. Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II. The European Journal of Surgery = Acta Chirurgica. 166: 289-92. PMID 10817323 DOI: 10.1080/110241500750009104  0.683
1999 de Graaf JS, Dullaart RP, Zwierstra RP. Complications after bilateral adrenalectomy for phaeochromocytoma in multiple endocrine neoplasia type 2--a plea to conserve adrenal function. The European Journal of Surgery = Acta Chirurgica. 165: 843-6. PMID 10533758 DOI: 10.1080/11024159950189320  0.702
1997 Dullaart RP, Hoogenberg K, Riemens SC, Groener JE, van Tol A, Sluiter WJ, Stulp BK. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes. Diabetes. 46: 2082-7. PMID 9392500 DOI: 10.2337/diab.46.12.2082  0.804
1991 Dullaart RP, Groener JE, Dikkeschei BD, Erkelens DW, Doorenbos H. Elevated cholesteryl ester transfer protein activity in IDDM men who smoke. Possible factor for unfavorable lipoprotein profile. Diabetes Care. 14: 338-41. PMID 2060438 DOI: 10.2337/diacare.14.4.338  0.736
1990 Dullaart RP, Hoogenberg K, Groener JE, Dikkeschei LD, Erkelens DW, Doorenbos H. The activity of cholesteryl ester transfer protein is decreased in hypothyroidism: a possible contribution to alterations in high-density lipoproteins. European Journal of Clinical Investigation. 20: 581-7. PMID 2127747 DOI: 10.1111/j.1365-2362.1990.tb01904.x  0.746
1989 Dullaart RP, Groener JE, van Wijk H, Sluiter WJ, Erkelens DW. Alimentary lipemia-induced redistribution of cholesteryl ester between lipoproteins. Studies in normolipidemic, combined hyperlipidemic, and hypercholesterolemic men. Arteriosclerosis (Dallas, Tex.). 9: 614-22. PMID 2783075 DOI: 10.1161/01.atv.9.5.614  0.766
1989 Dullaart RP, Groener JE, Dikkeschei LD, Erkelens DW, Doorenbos H. Increased cholesterylester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus--its relationship with serum lipids. Diabetologia. 32: 14-9. PMID 2707515 DOI: 10.1007/BF00265398  0.736
1988 Erkelens DW, Dullaart RP. In vivo evidence for cholesterol ester and triglyceride exchange between high density lipoprotein and infused triglyceride rich particles in abetalipoproteinemia. Advances in Experimental Medicine and Biology. 243: 247-53. PMID 3223418 DOI: 10.1007/978-1-4613-0733-4_31  0.781
1987 Dullaart RP, Groener JE, Erkelens DW. Effect of the composition of very low and low density lipoproteins on the rate of cholesterylester transfer from high density lipoproteins in man, studied in vitro. European Journal of Clinical Investigation. 17: 241-8. PMID 3113969 DOI: 10.1111/j.1365-2362.1987.tb01243.x  0.751
Low-probability matches (unlikely to be authored by this person)
2011 Kappelle PJ, Bijzet J, Hazenberg BP, Dullaart RP. Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome. Archives of Medical Research. 42: 219-25. PMID 21722818 DOI: 10.1016/j.arcmed.2011.05.002  0.299
2013 Dullaart RP, Kwakernaak AJ, Dallinga-Thie GM. The positive relationship of serum paraoxonase-1 activity with apolipoprotein E is abrogated in metabolic syndrome. Atherosclerosis. 230: 6-11. PMID 23958245 DOI: 10.1016/j.atherosclerosis.2013.06.019  0.293
2011 Kappelle PJ, Lambert G, Dahlbäck B, Nielsen LB, Dullaart RP. Relationship of plasma apolipoprotein M with proprotein convertase subtilisin-kexin type 9 levels in non-diabetic subjects. Atherosclerosis. 214: 492-4. PMID 21122852 DOI: 10.1016/J.Atherosclerosis.2010.10.041  0.29
2007 Dullaart RP, de Vries R, Dallinga-Thie GM, Sluiter WJ, van Tol A. Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases. Clinical Endocrinology. 68: 375-81. PMID 17877759 DOI: 10.1111/j.1365-2265.2007.03049.x  0.288
2011 Constantinides A, van Pelt LJ, van Leeuwen JJ, de Vries R, Tio RA, van der Horst IC, Sluiter WJ, Dullaart RP. Carotid intima media thickness is associated with plasma lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in patients with type 2 diabetes. European Journal of Clinical Investigation. 41: 820-7. PMID 21281278 DOI: 10.1111/j.1365-2362.2011.02471.x  0.278
2015 Annema W, Dikkers A, de Boer JF, Dullaart RP, Sanders JF, Bakker SJ, Tietge UJ. HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients. Journal of the American Society of Nephrology : Jasn. PMID 26319244 DOI: 10.1681/ASN.2014090857  0.274
2013 Deetman PE, Kwakernaak AJ, Bakker SJ, Dullaart RP. Low-normal free thyroxine confers decreased serum bilirubin in type 2 diabetes mellitus. Thyroid : Official Journal of the American Thyroid Association. 23: 1367-73. PMID 23638994 DOI: 10.1089/thy.2013.0156  0.267
2007 Dullaart RP, de Vries R, van Tol A, Sluiter WJ. Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender. European Journal of Endocrinology. 156: 387-94. PMID 17322499 DOI: 10.1530/EJE-06-0681  0.263
2010 Sofat R, Hingorani AD, Smeeth L, Humphries SE, Talmud PJ, Cooper J, Shah T, Sandhu MS, Ricketts SL, Boekholdt SM, Wareham N, Khaw KT, Kumari M, Kivimaki M, Marmot M, ... ... Dullaart RP, et al. Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms. Circulation. 121: 52-62. PMID 20026784 DOI: 10.1161/Circulationaha.109.865444  0.257
2013 Triolo M, de Boer JF, Annema W, Kwakernaak AJ, Tietge UJ, Dullaart RP. Low normal free T4 confers decreased high-density lipoprotein antioxidative functionality in the context of hyperglycaemia. Clinical Endocrinology. 79: 416-23. PMID 23278171 DOI: 10.1111/cen.12138  0.256
2016 Gruppen EG, Connelly MA, Dullaart RP. Higher circulating GlycA, a pro-inflammatory glycoprotein biomarker, relates to lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in diabetic or metabolic syndrome subjects. Journal of Clinical Lipidology. 10: 512-8. PMID 27206938 DOI: 10.1016/j.jacl.2015.11.009  0.254
2016 Leberkühne LJ, Ebtehaj S, Dimova LG, Dikkers A, Dullaart RP, Bakker SJ, Tietge UJ. The predictive value of the antioxidative function of HDL for cardiovascular disease and graft failure in renal transplant recipients. Atherosclerosis. 249: 181-5. PMID 27107804 DOI: 10.1016/j.atherosclerosis.2016.04.008  0.254
2014 Dullaart RP, Annema W, Tio RA, Tietge UJ. The HDL anti-inflammatory function is impaired in myocardial infarction and may predict new cardiac events independent of HDL cholesterol. Clinica Chimica Acta; International Journal of Clinical Chemistry. 433: 34-8. PMID 24613518 DOI: 10.1016/j.cca.2014.02.026  0.244
2016 Eppinga RN, Hartman MH, van Veldhuisen DJ, Lexis CP, Connelly MA, Lipsic E, van der Horst IC, van der Harst P, Dullaart RP. Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial. Plos One. 11: e0145719. PMID 26808474 DOI: 10.1371/journal.pone.0145719  0.241
2008 Thompson A, Di Angelantonio E, Sarwar N, Erqou S, Saleheen D, Dullaart RP, Keavney B, Ye Z, Danesh J. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. Jama. 299: 2777-88. PMID 18560005 DOI: 10.1001/jama.299.23.2777  0.241
2014 Corsetti JP, Gansevoort RT, Bakker SJ, Sparks CE, Vart P, Dullaart RP. Apolipoprotein B attenuates albuminuria-associated cardiovascular disease in prevention of renal and vascular endstage disease (PREVEND) participants. Journal of the American Society of Nephrology : Jasn. 25: 2906-15. PMID 24854276 DOI: 10.1681/ASN.2013121256  0.24
2012 Dullaart RP, Kappelle PJ, de Vries R. Lower carotid intima media thickness is predicted by higher serum bilirubin in both non-diabetic and Type 2 diabetic subjects. Clinica Chimica Acta; International Journal of Clinical Chemistry. 414: 161-5. PMID 23010146 DOI: 10.1016/j.cca.2012.08.029  0.238
2011 de Vries R, Kappelle PJ, Dallinga-Thie GM, Dullaart RP. Plasma phospholipid transfer protein activity is independently determined by obesity and insulin resistance in non-diabetic subjects. Atherosclerosis. 217: 253-9. PMID 21481395 DOI: 10.1016/j.atherosclerosis.2011.03.021  0.237
2013 Deetman PE, Bakker SJ, Dullaart RP. High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome. Cardiovascular Diabetology. 12: 166. PMID 24209691 DOI: 10.1186/1475-2840-12-166  0.229
2012 Kwakernaak AJ, Lambert G, Dullaart RP. Relationship of proprotein convertase subtilisin-kexin type 9 levels with resistin in lean and obese subjects. Clinical Biochemistry. 45: 1522-4. PMID 22809551 DOI: 10.1016/j.clinbiochem.2012.07.002  0.227
2004 Vogt L, Laverman GD, Dullaart RP, Navis G. Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reduction. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 19: 5-8. PMID 14671028 DOI: 10.1093/ndt/gfg497  0.221
2016 Corsetti JP, Gansevoort RT, Bakker SJ, Dullaart RP. Apolipoprotein E levels and apolipoprotein E genotypes in incident cardiovascular disease risk in subjects of the Prevention of Renal and Vascular End-stage disease study. Journal of Clinical Lipidology. 10: 842-50. PMID 27578115 DOI: 10.1016/j.jacl.2016.03.003  0.204
2016 Connelly MA, Gruppen EG, Wolak-Dinsmore J, Matyus SP, Riphagen IJ, Shalaurova I, Bakker SJ, Otvos JD, Dullaart RP. GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study. Clinica Chimica Acta; International Journal of Clinical Chemistry. 452: 10-7. PMID 26549655 DOI: 10.1016/J.Cca.2015.11.001  0.201
2013 van Eersel ME, Joosten H, Gansevoort RT, Dullaart RP, Slaets JP, Izaks GJ. The interaction of age and type 2 diabetes on executive function and memory in persons aged 35 years or older. Plos One. 8: e82991. PMID 24367577 DOI: 10.1371/journal.pone.0082991  0.198
2015 Dullaart RP, Gruppen EG, Connelly MA, Otvos JD, Lefrandt JD. GlycA, a biomarker of inflammatory glycoproteins, is more closely related to the leptin/adiponectin ratio than to glucose tolerance status. Clinical Biochemistry. 48: 811-4. PMID 25977069 DOI: 10.1016/J.Clinbiochem.2015.05.001  0.192
2009 Krikken JA, Dallinga-Thie GM, Navis G, Dullaart RP. Renin-angiotensin-aldosterone responsiveness to low sodium and blood pressure reactivity to angiotensin-II are unrelated to cholesteryl ester transfer protein mass in healthy subjects. Expert Opinion On Therapeutic Targets. 12: 1321-8. PMID 18851690 DOI: 10.1517/14728222.12.11.1321  0.191
2014 Li N, van der Sijde MR, Bakker SJ, Dullaart RP, van der Harst P, Gansevoort RT, Elbers CC, Wijmenga C, Snieder H, Hofker MH, Fu J. Pleiotropic effects of lipid genes on plasma glucose, HbA1c, and HOMA-IR levels. Diabetes. 63: 3149-58. PMID 24722249 DOI: 10.2337/Db13-1800  0.191
2007 Lely AT, Krikken JA, Bakker SJ, Boomsma F, Dullaart RP, Wolffenbuttel BH, Navis G. Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men. The Journal of Clinical Endocrinology and Metabolism. 92: 1821-6. PMID 17341566 DOI: 10.1210/jc.2006-2092  0.185
2014 Dullaart RP, Tietge UJ, Kwakernaak AJ, Dikkeschei BD, Perton F, Tio RA. Alterations in plasma lecithin:cholesterol acyltransferase and myeloperoxidase in acute myocardial infarction: implications for cardiac outcome. Atherosclerosis. 234: 185-92. PMID 24661908 DOI: 10.1016/j.atherosclerosis.2014.02.026  0.185
2015 van Tienhoven-Wind LJ, Dullaart RP. Low-normal thyroid function and the pathogenesis of common cardio-metabolic disorders. European Journal of Clinical Investigation. 45: 494-503. PMID 25690560 DOI: 10.1111/eci.12423  0.178
2012 Dullaart RP, Oomen PH, Sluiter WJ. Circulating vascular endothelial growth factor is unaffected by acute hyperglycemia and hyperinsulinemia in type 1 diabetes mellitus. European Journal of Internal Medicine. 18: 193-5. PMID 17449390 DOI: 10.1016/j.ejim.2006.11.006  0.174
2009 Dullaart RP, Plomgaard P, de Vries R, Dahlbäck B, Nielsen LB. Plasma apolipoprotein M is reduced in metabolic syndrome but does not predict intima media thickness. Clinica Chimica Acta; International Journal of Clinical Chemistry. 406: 129-33. PMID 19539616 DOI: 10.1016/J.Cca.2009.06.010  0.174
2012 Eskes SA, Endert E, Fliers E, Geskus RB, Dullaart RP, Links TP, Wiersinga WM. Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial. The Journal of Clinical Endocrinology and Metabolism. 97: 499-506. PMID 22130792 DOI: 10.1210/Jc.2011-2390  0.165
2021 Heidemann BE, Wolters FJ, Kavousi M, Gruppen EG, Dullaart RP, Marais AD, Visseren FL, Koopal C. Adiposity and the development of dyslipidemia in APOE ε2 homozygous subjects: A longitudinal analysis in two population-based cohorts. Atherosclerosis. 325: 57-62. PMID 33892328 DOI: 10.1016/j.atherosclerosis.2021.04.001  0.162
2010 Dullaart RP, Kappelle PJ, Dallinga-Thie GM. Carotid intima media thickness is associated with plasma adiponectin but not with the leptin:adiponectin ratio independently of metabolic syndrome. Atherosclerosis. 211: 393-6. PMID 20398901 DOI: 10.1016/j.atherosclerosis.2010.03.024  0.157
2014 Dullaart RP, van den Berg EH, van der Klauw MM, Blokzijl H. Low normal thyroid function attenuates serum alanine aminotransferase elevations in the context of metabolic syndrome and insulin resistance in white people. Clinical Biochemistry. 47: 1028-32. PMID 24769275 DOI: 10.1016/j.clinbiochem.2014.04.016  0.156
2014 Dullaart RP, Boersema J, Lefrandt JD, Wolffenbuttel BH, Bakker SJ. The inverse association of incident cardiovascular disease with plasma bilirubin is unaffected by adiponectin. Atherosclerosis. 235: 380-3. PMID 24929286 DOI: 10.1016/j.atherosclerosis.2014.05.938  0.156
2003 Kerstens MN, van der Kleij FG, Boonstra AH, Sluiter WJ, Koerts J, Navis G, Dullaart RP. Salt loading affects cortisol metabolism in normotensive subjects: relationships with salt sensitivity. The Journal of Clinical Endocrinology and Metabolism. 88: 4180-5. PMID 12970284 DOI: 10.1210/jc.2002-021625  0.155
2017 van Tienhoven-Wind LJ, Dullaart RP. Increased leptin/adiponectin ratio relates to low-normal thyroid function in metabolic syndrome. Lipids in Health and Disease. 16: 6. PMID 28077136 DOI: 10.1186/s12944-016-0403-4  0.147
2016 Connelly MA, Gruppen EG, Otvos JD, Dullaart RP. Inflammatory glycoproteins in cardiometabolic disorders, autoimmune diseases and cancer. Clinica Chimica Acta; International Journal of Clinical Chemistry. 459: 177-186. PMID 27312321 DOI: 10.1016/J.Cca.2016.06.012  0.146
2014 Deetman PE, Bakker SJ, Kwakernaak AJ, Navis G, Dullaart RP. The relationship of the anti-oxidant bilirubin with free thyroxine is modified by insulin resistance in euthyroid subjects. Plos One. 9: e90886. PMID 24595410 DOI: 10.1371/journal.pone.0090886  0.139
2013 Dullaart RP, van Pelt LJ, Kwakernaak AJ, Dikkeschei BD, van der Horst IC, Tio RA. Plasma lipoprotein-associated phospholipase A2 mass is elevated in STEMI compared to non-STEMI patients but does not discriminate between myocardial infarction and non-cardiac chest pain. Clinica Chimica Acta; International Journal of Clinical Chemistry. 424: 136-40. PMID 23756128 DOI: 10.1016/j.cca.2013.05.026  0.138
2017 van den Berg EH, van Tienhoven-Wind LJ, Amini M, Schreuder TC, Faber KN, Blokzijl H, Dullaart RP. Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study. Metabolism: Clinical and Experimental. 67: 62-71. PMID 28081779 DOI: 10.1016/j.metabol.2016.11.002  0.134
2016 Werumeus Buning J, van Faassen M, Brummelman P, Dullaart RP, van den Berg G, van der Klauw MM, Kerstens MN, Stegeman CA, Muller Kobold AC, Kema IP, Wolffenbuttel BH, van Beek AP. Effects of Hydrocortisone on the Regulation of Blood Pressure: Results From a Randomized Controlled Trial. The Journal of Clinical Endocrinology and Metabolism. 101: 3691-3699. PMID 27490921 DOI: 10.1210/jc.2016-2216  0.13
2011 Kerstens MN, Kobold AC, Volmer M, Koerts J, Sluiter WJ, Dullaart RP. Reference values for aldosterone-renin ratios in normotensive individuals and effect of changes in dietary sodium consumption. Clinical Chemistry. 57: 1607-11. PMID 21865483 DOI: 10.1373/clinchem.2011.165662  0.129
2003 Kerstens MN, Navis G, Dullaart RP. Does a reduced 11 beta HSD type 2 activity contribute to sodium retention in the nephrotic syndrome? Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 18: 620; author reply 62. PMID 12584292 DOI: 10.1093/ndt/18.3.620  0.124
2016 Gruppen EG, Connelly MA, Vart P, Otvos JD, Bakker SJ, Dullaart RP. GlycA, a novel proinflammatory glycoprotein biomarker, and high-sensitivity C-reactive protein are inversely associated with sodium intake after controlling for adiposity: the Prevention of Renal and Vascular End-Stage Disease study. The American Journal of Clinical Nutrition. PMID 27305953 DOI: 10.3945/Ajcn.116.133744  0.122
2016 Osinga TE, Kema IP, Kerstens MN, de Jong WH, van Faassen M, Dullaart RP, Links TP, van der Horst-Schrivers AN. No influence of antihypertensive agents on plasma free metanephrines. Clinical Biochemistry. PMID 27291837 DOI: 10.1016/j.clinbiochem.2016.06.004  0.121
2013 Osinga TE, van den Eijnden MH, Kema IP, Kerstens MN, Dullaart RP, de Jong WH, Sluiter WJ, Links TP, van der Horst-Schrivers AN. Unilateral and bilateral adrenalectomy for pheochromocytoma requires adjustment of urinary and plasma metanephrine reference ranges. The Journal of Clinical Endocrinology and Metabolism. 98: 1076-83. PMID 23365125 DOI: 10.1210/jc.2012-3418  0.119
2015 Kunutsor SK, Bakker SJ, Kootstra-Ros JE, Blokzijl H, Gansevoort RT, Dullaart RP. Inverse linear associations between liver aminotransferases and incident cardiovascular disease risk: The PREVEND study. Atherosclerosis. 243: 138-47. PMID 26386210 DOI: 10.1016/j.atherosclerosis.2015.09.006  0.117
2014 Bolton JL, Hayward C, Direk N, Lewis JG, Hammond GL, Hill LA, Anderson A, Huffman J, Wilson JF, Campbell H, Rudan I, Wright A, Hastie N, Wild SH, Velders FP, ... ... Dullaart RP, et al. Genome wide association identifies common variants at the SERPINA6/SERPINA1 locus influencing plasma cortisol and corticosteroid binding globulin. Plos Genetics. 10: e1004474. PMID 25010111 DOI: 10.1371/Journal.Pgen.1004474  0.115
2015 Dullaart RP, Van Haperen R, Van Den Born J, Van Goor H, De Crom R, Van Tol A. No renal phenotype in human phospholipid transfer protein transgenic apolipoprotein E deficient mice despite severe aortic atherosclerosis. Clinical Laboratory. 60: 1659-62. PMID 25651711 DOI: 10.7754/clin.lab.2014.131232  0.115
2015 van Doorn J, van de Hoef W, Dullaart RP. Quantitative analysis of the concentrations of IGFs and several IGF-binding proteins in a large fibrous abdominal tumor and the circulation of a patient with hypoglycemia. Biofactors (Oxford, England). 41: 183-9. PMID 26073062 DOI: 10.1002/biof.1212  0.114
2009 Bayley JP, Grimbergen AE, van Bunderen PA, van der Wielen M, Kunst HP, Lenders JW, Jansen JC, Dullaart RP, Devilee P, Corssmit EP, Vriends AH, Losekoot M, Weiss MM. The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patients. Bmc Medical Genetics. 10: 34. PMID 19368708 DOI: 10.1186/1471-2350-10-34  0.109
2015 Gruppen EG, Riphagen IJ, Connelly MA, Otvos JD, Bakker SJ, Dullaart RP. GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function. Plos One. 10: e0139057. PMID 26398105 DOI: 10.1371/Journal.Pone.0139057  0.106
2017 van den Berg EH, Amini M, Schreuder TC, Dullaart RP, Faber KN, Alizadeh BZ, Blokzijl H. Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort. Plos One. 12: e0171502. PMID 28152105 DOI: 10.1371/journal.pone.0171502  0.105
2004 Kerstens MN, Navis G, Dullaart RP. Salt sensitivity and 11beta-hydroxysteroid dehydrogenase type 2 activity. American Journal of Hypertension. 17: 283-4. PMID 15001207 DOI: 10.1016/j.amjhyper.2003.11.008  0.104
2004 Hovingh GK, Brownlie A, Bisoendial RJ, Dube MP, Levels JH, Petersen W, Dullaart RP, Stroes ES, Zwinderman AH, de Groot E, Hayden MR, Kuivenhoven JA, Kastelein JJ. A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease. Journal of the American College of Cardiology. 44: 1429-35. PMID 15464323 DOI: 10.1016/J.Jacc.2004.06.070  0.102
2005 Lam MG, Lips CJ, Jager PL, Dullaart RP, Lentjes EG, van Rijk PP, de Klerk JM. Repeated [131I]metaiodobenzylguanidine therapy in two patients with malignant pheochromocytoma. The Journal of Clinical Endocrinology and Metabolism. 90: 5888-95. PMID 16046591 DOI: 10.1210/jc.2004-2290  0.102
2010 Lutgers HL, Graaff R, de Vries R, Smit AJ, Dullaart RP. Carotid artery intima media thickness associates with skin autofluoresence in non-diabetic subjects without clinically manifest cardiovascular disease. European Journal of Clinical Investigation. 40: 812-7. PMID 20597962 DOI: 10.1111/j.1365-2362.2010.02329.x  0.101
2016 Werumeus Buning J, Kootstra-Ros JE, Brummelman P, van den Berg G, van der Klauw M, Wolffenbuttel BH, van Beek AP, Dullaart RP. Higher hydrocortisone dose increases bilirubin in hypopituitary patients- results from an RCT. European Journal of Clinical Investigation. 46: 475-80. PMID 26999644 DOI: 10.1111/eci.12624  0.099
2015 Osinga TE, van der Horst-Schrivers AN, van Faassen M, Kerstens MN, Dullaart RP, Peters MA, van der Laan BF, de Bock GH, Links TP, Kema IP. Dopamine concentration in blood platelets is elevated in patients with head and neck paragangliomas. Clinical Chemistry and Laboratory Medicine. PMID 26677887 DOI: 10.1515/cclm-2015-0631  0.098
2015 Kunutsor SK, Bakker SJ, Kootstra-Ros JE, Gansevoort RT, Gregson J, Dullaart RP. Serum Alkaline Phosphatase and Risk of Incident Cardiovascular Disease: Interrelationship with High Sensitivity C-Reactive Protein. Plos One. 10: e0132822. PMID 26167920 DOI: 10.1371/journal.pone.0132822  0.093
2011 Izaks GJ, Gansevoort RT, van der Knaap AM, Navis G, Dullaart RP, Slaets JP. The association of APOE genotype with cognitive function in persons aged 35 years or older. Plos One. 6: e27415. PMID 22110642 DOI: 10.1371/journal.pone.0027415  0.093
2012 Golestani R, Slart RH, Dullaart RP, Glaudemans AW, Zeebregts CJ, Boersma HH, Tio RA, Dierckx RA. Adverse cardiovascular effects of anabolic steroids: pathophysiology imaging. European Journal of Clinical Investigation. 42: 795-803. PMID 22299602 DOI: 10.1111/j.1365-2362.2011.02642.x  0.092
2008 de Bruin D, de Jong IJ, Arts EG, Nuver J, Dullaart RP, Sluiter WJ, Hoekstra HJ, Sleijfer DT, Gietema JA. Semen quality in men with disseminated testicular cancer: relation with human chorionic gonadotropin beta-subunit and pituitary gonadal hormones. Fertility and Sterility. 91: 2481-6. PMID 18440530 DOI: 10.1016/j.fertnstert.2008.03.016  0.091
2015 Dullaart RP, Gruppen EG, Connelly MA, Lefrandt JD. A pro-inflammatory glycoprotein biomarker is associated with lower bilirubin in metabolic syndrome. Clinical Biochemistry. 48: 1045-7. PMID 26129880 DOI: 10.1016/j.clinbiochem.2015.06.016  0.091
2016 de Vos LC, Lefrandt JD, Dullaart RP, Zeebregts CJ, Smit AJ. Advanced glycation end products: An emerging biomarker for adverse outcome in patients with peripheral artery disease. Atherosclerosis. PMID 27751506 DOI: 10.1016/j.atherosclerosis.2016.10.012  0.089
2007 Dullaart RP, de Vries R, Roozendaal C, Kobold AC, Sluiter WJ. Carotid artery intima media thickness is inversely related to serum free thyroxine in euthyroid subjects. Clinical Endocrinology. 67: 668-73. PMID 17596198 DOI: 10.1111/j.1365-2265.2007.02943.x  0.087
2012 Izaks GJ, van der Knaap AM, Gansevoort RT, Navis G, Slaets JP, Dullaart RP. Cholesteryl Ester Transfer Protein (CETP) genotype and cognitive function in persons aged 35 years or older. Neurobiology of Aging. 33: 1851.e7-16. PMID 22464147 DOI: 10.1016/j.neurobiolaging.2012.02.022  0.086
2015 Werumeus Buning J, Brummelman P, Koerts J, Dullaart RP, van den Berg G, van der Klauw MM, Tucha O, Wolffenbuttel BH, van Beek AP. The effects of two different doses of hydrocortisone on cognition in patients with secondary adrenal insufficiency--results from a randomized controlled trial. Psychoneuroendocrinology. 55: 36-47. PMID 25705800 DOI: 10.1016/j.psyneuen.2015.02.001  0.086
2006 Asselbergs FW, Moore JH, Berg MPvd, Rimm EB, Boer RAd, Dullaart RP, Navis G, Gilst WHv. A role for CETP TaqIB polymorphism in determining susceptibility to atrial fibrillation: a nested case control study Bmc Medical Genetics. 7: 39-39. PMID 16623947 DOI: 10.1186/1471-2350-7-39  0.083
2005 van Cruijsen N, Dullaart RP, Wit HP, Albers FW. Analysis of cortisol and other stress-related hormones in patients with Ménière's disease. Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 26: 1214-9. PMID 16272945 DOI: 10.1097/01.mao.0000179528.24909.ba  0.082
2014 Slagter SN, van Vliet-Ostaptchouk JV, Vonk JM, Boezen HM, Boezen HM, Dullaart RP, Kobold AC, Feskens EJ, van Beek AP, van der Klauw MM, Wolffenbuttel BH. Combined effects of smoking and alcohol on metabolic syndrome: the LifeLines cohort study. Plos One. 9: e96406. PMID 24781037 DOI: 10.1371/journal.pone.0096406  0.082
2015 Kunutsor SK, Bakker SJ, Gansevoort RT, Chowdhury R, Dullaart RP. Circulating total bilirubin and risk of incident cardiovascular disease in the general population. Arteriosclerosis, Thrombosis, and Vascular Biology. 35: 716-24. PMID 25593130 DOI: 10.1161/ATVBAHA.114.304929  0.08
2004 Kerstens MN, van der Kleij FG, Boonstra AH, Sluiter WJ, van der Molen JC, Navis G, Dullaart RP. Angiotensin administration stimulates renal 11 beta-hydroxysteroid dehydrogenase activity in healthy men. Kidney International. 65: 2065-70. PMID 15149319 DOI: 10.1111/j.1523-1755.2004.00626.x  0.078
2017 Osinga TE, Links TP, Dullaart RP, Pacak K, van der Horst-Schrivers AN, Kerstens MN, Kema IP. Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 28264974 DOI: 10.1096/fj.201601131R  0.078
2015 Kunutsor SK, Bakker SJ, James RW, Dullaart RP. Serum paraoxonase-1 activity and risk of incident cardiovascular disease: The PREVEND study and meta-analysis of prospective population studies. Atherosclerosis. 245: 143-154. PMID 26724525 DOI: 10.1016/j.atherosclerosis.2015.12.021  0.077
2011 Van Der Horst-Schrivers AN, Osinga TE, Kema IP, Van Der Laan BF, Dullaart RP. Dopamine excess in patients with head and neck paragangliomas. Anticancer Research. 30: 5153-8. PMID 21187504  0.074
2011 Brummelman P, Elderson MF, Dullaart RP, van den Bergh AC, Timmer CA, van den Berg G, Koerts J, Tucha O, Wolffenbuttel BH, van Beek AP. Cognitive functioning in patients treated for nonfunctioning pituitary macroadenoma and the effects of pituitary radiotherapy. Clinical Endocrinology. 74: 481-7. PMID 21133979 DOI: 10.1111/j.1365-2265.2010.03947.x  0.072
2004 van den Bergh AC, Hoving MA, Links TP, Dullaart RP, Ranchor AV, ter Weeme CA, Canrinus AA, Szabó BG, Pott JW. Radiation optic neuropathy after external beam radiation therapy for acromegaly: report of two cases. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 68: 101-3. PMID 12972303 DOI: 10.1016/s0167-8140(03)00201-9  0.072
2023 Magnussen C, Ojeda FM, Leong DP, Alegre-Diaz J, Amouyel P, Aviles-Santa L, De Bacquer D, Ballantyne CM, Bernabé-Ortiz A, Bobak M, Brenner H, Carrillo-Larco RM, de Lemos J, Dobson A, Dörr M, ... ... Dullaart RP, et al. Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality. The New England Journal of Medicine. PMID 37632466 DOI: 10.1056/NEJMoa2206916  0.071
2005 Kramer AB, Roozendaal C, Dullaart RP. Familial occurrence of subacute thyroiditis associated with human leukocyte antigen-B35. Thyroid : Official Journal of the American Thyroid Association. 14: 544-7. PMID 15307945 DOI: 10.1089/1050725041517048  0.071
2015 Brummelman P, Sattler MG, Meiners LC, van den Berg G, van der Klauw MM, Elderson MF, Dullaart RP, Koerts J, Werumeus Buning J, Tucha O, Wolffenbuttel BH, van den Bergh AC, van Beek AP. Cognition and brain abnormalities on MRI in pituitary patients. European Journal of Radiology. 84: 295-300. PMID 25523821 DOI: 10.1016/j.ejrad.2014.11.033  0.071
2016 Werumeus Buning J, Brummelman P, Koerts J, Dullaart RP, van den Berg G, van der Klauw MM, Sluiter WJ, Tucha O, Wolffenbuttel BH, van Beek AP. Hydrocortisone Dose Influences Pain, Depressive Symptoms and Perceived Health in Adrenal Insufficiency: A Randomized Controlled Trial. Neuroendocrinology. 103: 771-8. PMID 26646751 DOI: 10.1159/000442985  0.068
2008 Koopmans KP, Jager PL, Kema IP, Kerstens MN, Albers F, Dullaart RP. 111In-octreotide is superior to 123I-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 1232-7. PMID 18632829 DOI: 10.2967/jnumed.107.047738  0.067
2016 Agra RM, Al-Daghri NM, Badimon L, Bodi V, Carbone F, Chen M, Cubedo J, Dullaart RP, Eiras S, García-Monzón C, Gary T, Gnoni A, González-Rodríguez Á, Gremmel T, Hafner F, et al. Research update for articles published in EJCI in 2014. European Journal of Clinical Investigation. PMID 27571922 DOI: 10.1111/eci.12671  0.067
2012 Brummelman P, Koerts J, Dullaart RP, van den Berg G, Tucha O, Wolffenbuttel BH, van Beek AP. Effects of previous growth hormone excess and current medical treatment for acromegaly on cognition. European Journal of Clinical Investigation. 42: 1317-24. PMID 23083406 DOI: 10.1111/j.1365-2362.2012.02721.x  0.066
2024 Kittithaworn A A, Dogra P, Saini J, Gruppen EG, Atkinson E, Achenbach S, Yu K, Thangamuthu K, Connelly MA, Dullaart RP, Bancos I. Enhanced chronic inflammation and increased branched chain amino acids in adrenal disorders: a cross-sectional study. The Journal of Clinical Endocrinology and Metabolism. PMID 38546526 DOI: 10.1210/clinem/dgae204  0.062
2013 Alkemade GM, Bakker M, Rikhof B, IJpma FF, van Ginkel RJ, Kluin PM, van Doorn J, Dullaart RP. Hypoglycemia in a patient with a big "big"-IGF-II-producing tumor. The Journal of Clinical Endocrinology and Metabolism. 98: 3113-4. PMID 23788691 DOI: 10.1210/jc.2013-2170  0.06
2004 van den Bergh AC, Schoorl MA, Dullaart RP, van der Vliet AM, Szabó BG, ter Weeme CA, Pott JW. Lack of radiation optic neuropathy in 72 patients treated for pituitary adenoma. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 24: 200-5. PMID 15348984 DOI: 10.1097/00041327-200409000-00003  0.06
2014 Kunutsor SK, Bakker SJ, Kootstra-Ros JE, Gansevoort RT, Dullaart RP. Circulating gamma glutamyltransferase and prediction of cardiovascular disease. Atherosclerosis. 238: 356-64. PMID 25555268 DOI: 10.1016/j.atherosclerosis.2014.12.045  0.058
2014 de Vos LC, Mulder DJ, Smit AJ, Dullaart RP, Kleefstra N, Lijfering WM, Kamphuisen PW, Zeebregts CJ, Lefrandt JD. Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 34: 933-8. PMID 24526694 DOI: 10.1161/ATVBAHA.113.302731  0.057
2016 Eisenga MF, Dullaart RP, Berger SP, Sloan JH, de Vries AP, Bakker SJ, Gaillard CA. Association of Hepcidin-25 with Survival after Kidney Transplantation. European Journal of Clinical Investigation. PMID 27696386 DOI: 10.1111/eci.12682  0.055
2004 Phan TT, van Tol KM, Links TP, Piers DA, de Vries EG, Dullaart RP, Jager PL. Diagnostic I-131 scintigraphy in patients with differentiated thyroid cancer: no additional value of higher scan dose. Annals of Nuclear Medicine. 18: 641-6. PMID 15682843  0.053
2016 Osinga TE, van der Horst-Schrivers AN, van Faassen M, Kerstens MN, Dullaart RP, Pacak K, Links TP, Kema IP. Mass spectrometric quantification of salivary metanephrines-A study in healthy subjects. Clinical Biochemistry. PMID 26874200 DOI: 10.1016/j.clinbiochem.2016.02.003  0.046
2016 Chaker L, Baumgartner C, den Elzen WP, Collet TH, Ikram MA, Blum MR, Dehghan A, Drechsler C, Luben RN, Portegies ML, Iervasi G, Medici M, Stott DJ, Dullaart RP, Ford I, et al. Thyroid Function within the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis. The Journal of Clinical Endocrinology and Metabolism. jc20162255. PMID 27603906 DOI: 10.1210/Jc.2016-2255  0.044
2009 Dullaart RP, van der Horst-Schrivers AN, Koopmans KP. New imaging approaches to phaeochromocytomas and paragangliomas. Clinical Endocrinology. 72: 568-9; author reply . PMID 19769625 DOI: 10.1111/j.1365-2265.2009.03705.x  0.04
2017 Eppinga RN, Kofink D, Dullaart RP, Dalmeijer GW, Lipsic E, van Veldhuisen DJ, van der Horst IC, Asselbergs FW, van der Harst P. Effect of Metformin on Metabolites and Relation With Myocardial Infarct Size and Left Ventricular Ejection Fraction After Myocardial Infarction. Circulation. Cardiovascular Genetics. 10. PMID 28100626 DOI: 10.1161/CIRCGENETICS.116.001564  0.035
2002 van Tol KM, Jager PL, Piers DA, Pruim J, de Vries EG, Dullaart RP, Links TP. Better yield of (18)fluorodeoxyglucose-positron emission tomography in patients with metastatic differentiated thyroid carcinoma during thyrotropin stimulation. Thyroid : Official Journal of the American Thyroid Association. 12: 381-7. PMID 12097198 DOI: 10.1089/105072502760043459  0.035
2008 Dullaart RP, Kobold AC, van Tol A. Torcetrapib and coronary events. The New England Journal of Medicine. 358: 1863; author reply 1. PMID 18437725  0.035
2016 Eijkelenkamp K, Osinga TE, de Jong MM, Sluiter WJ, Dullaart RP, Links TP, Kerstens MN, van der Horst-Schrivers AN. Calculating the optimal surveillance for head and neck paraganglioma in SDHB-mutation carriers. Familial Cancer. PMID 27573198 DOI: 10.1007/s10689-016-9923-3  0.035
2015 Deetman PE, Said MY, Kromhout D, Dullaart RP, Kootstra-Ros JE, Sanders JS, Seelen MA, Gans RO, Navis G, Joosten MM, Bakker SJ. Urinary Urea Excretion and Long-term Outcome After Renal Transplantation. Transplantation. 99: 1009-15. PMID 25393159 DOI: 10.1097/TP.0000000000000464  0.034
2015 Osinga TE, Korpershoek E, de Krijger RR, Kerstens MN, Dullaart RP, Kema IP, van der Laan BF, van der Horst-Schrivers AN, Links TP. Catecholamine-Synthesizing Enzymes Are Expressed in Parasympathetic Head and Neck Paraganglioma Tissue. Neuroendocrinology. 101: 289-95. PMID 25677368 DOI: 10.1159/000377703  0.032
2012 Brummelman P, Sattler MG, Meiners LC, Elderson MF, Dullaart RP, van den Berg G, Koerts J, Tucha O, Wolffenbuttel BH, van den Bergh AC, van Beek AP. Cognitive performance after postoperative pituitary radiotherapy: a dosimetric study of the hippocampus and the prefrontal cortex. European Journal of Endocrinology. 166: 171-9. PMID 22071311 DOI: 10.1530/EJE-11-0749  0.029
2019 Wildisen L, Moutzouri E, Beglinger S, Syrogiannouli L, Cappola AR, Åsvold BO, Bakker SJL, Ceresini G, Dullaart R, Ferrucci L, Grabe H, Jukema JW, Nauck M, Trompet S, Völzke H, et al. Subclinical thyroid dysfunction and depressive symptoms: protocol for a systematic review and individual participant data meta-analysis of prospective cohort studies. Bmj Open. 9: e029716. PMID 31350252 DOI: 10.1136/bmjopen-2019-029716  0.029
2015 Klein Hesselink EN, Lefrandt JD, Schuurmans EP, Burgerhof JG, Groen B, Gansevoort RT, van der Horst-Schrivers AN, Dullaart RP, Van Gelder IC, Brouwers AH, Rienstra M, Links TP. Increased Risk of Atrial Fibrillation After Treatment for Differentiated Thyroid Carcinoma. The Journal of Clinical Endocrinology and Metabolism. 100: 4563-9. PMID 26480284 DOI: 10.1210/jc.2015-2782  0.028
2003 Kerstens MN, Dullaart RP. Cortisol metabolism and glucose intolerance. The Journal of Clinical Endocrinology and Metabolism. 88: 2951; author reply 2. PMID 12788912 DOI: 10.1210/jc.2003-030356  0.025
2010 Lutgers HL, Vergragt J, Dong PV, de Vries J, Dullaart RP, van den Berg G, Ligtenberg JJ. Severe hypercortisolism: a medical emergency requiring urgent intervention. Critical Care Medicine. 38: 1598-601. PMID 20495451 DOI: 10.1097/CCM.0b013e3181e47b7a  0.021
2012 Zittema D, Boertien WE, van Beek AP, Dullaart RP, Franssen CF, de Jong PE, Meijer E, Gansevoort RT. Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment. Clinical Journal of the American Society of Nephrology : Cjasn. 7: 906-13. PMID 22516290 DOI: 10.2215/CJN.11311111  0.019
2015 Madsen Svarrer EM, Andersen HØ, Helvind M, Slagman MC, Navis G, Dullaart RP, Dahlbäck B, Nielsen LB. Urinary apolipoprotein M as a biomarker of acute kidney injury in children undergoing heart surgery. Biomarkers in Medicine. PMID 26642098 DOI: 10.2217/bmm.15.105  0.018
2004 van den Bergh AC, Dullaart RP, Hoving MA, Links TP, ter Weeme CA, Szabó BG, Pott JW. Radiation optic neuropathy after external beam radiation therapy for acromegaly. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 68: 95-100. PMID 12972302 DOI: 10.1016/s0167-8140(03)00202-0  0.017
2015 Chaker L, Baumgartner C, den Elzen WP, Ikram MA, Blum MR, Collet TH, Bakker SJ, Dehghan A, Drechsler C, Luben RN, Hofman A, Portegies ML, Medici M, Iervasi G, Stott DJ, ... ... Dullaart RP, et al. Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis. The Journal of Clinical Endocrinology and Metabolism. 100: 2181-91. PMID 25856213 DOI: 10.1210/Jc.2015-1438  0.016
2013 de Vos LC, Noordzij MJ, Mulder DJ, Smit AJ, Lutgers HL, Dullaart RP, Kamphuisen PW, Zeebregts CJ, Lefrandt JD. Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 33: 131-8. PMID 23139292 DOI: 10.1161/ATVBAHA.112.300016  0.012
2003 Dullaart RP, van Tol A. Letter in response to recent paper by Fournier et al. Atherosclerosis. 164: 379-80. PMID 12204811 DOI: 10.1016/s0021-9150(02)00039-4  0.01
Hide low-probability matches.